CSL Ltd. appointed Brian McNamee and Abbas Hussain as independent nonexecutive directors, effective Feb. 14, 2018.
McNamee will also serve as the board's chairman-elect. He previously served as the company's CEO and managing director, until his retirement in 2013.
Chairman John Shine will retire at the end of the 2018 annual general meeting, to be held October 2018.
Hussain was most recently global president, pharmaceutical at GlaxoSmithKline plc. He is currently a member of Immunocore Ltd.'s board.
